<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00962676</url>
  </required_header>
  <id_info>
    <org_study_id>4-2009-0129</org_study_id>
    <nct_id>NCT00962676</nct_id>
  </id_info>
  <brief_title>Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <brief_summary>
    <textblock>
      For diagnosis of active tuberculosis, interferon-γ release assay based mycobacterium
      tuberculosis specific antigen may show higher sensitivity than tuberculin skin test in
      immunocompromised patients. Therefore, interferon-γ release assay have a role as a rapid
      diagnostic adjunctive methods for active tuberculosis in immunocompromised patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">140</enrollment>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>immunocompromised group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-immunocompromised group</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        suspicious of tuberculosis, immunocompromised patients such cancer patients on
        chemotherapy, transplantation patients, patients with immunosuppressant
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient suspicious of active tuberculosis with immunocompromised condition

          -  Immunocompromised condition patients with

               1. solid cancer with chemotherapy

               2. hematologic malignancy

               3. organ transplantation

               4. immunosuppressant

               5. ESRD on renal replacement therapy

               6. diabetes

               7. advanced liver cirrhosis

        Exclusion Criteria:

          -  Patients with

               1. less than 20 years

               2. who don't agree the participation of study

               3. hypersensitivity history to tuberculin

               4. pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Yonsei Univ.</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2009</study_first_submitted>
  <study_first_submitted_qc>August 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2009</study_first_posted>
  <last_update_submitted>January 31, 2012</last_update_submitted>
  <last_update_submitted_qc>January 31, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>suspicious of tuberculosis</keyword>
  <keyword>immunocompromised patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

